DGX

The current price of Quest Diagnostics Inc. (DGX) is 242.77. Over the past 24 hours, the stock has changed by -0.76%. Follow the DGX chart for real-time price dynamics.

Quest Diagnostics Inc. trades under the ticker DGX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

DGX has changed by +0.06% over the last week, +4.29% over the last month, and +34.87% over the last year. Review the chart to see whether the current move is part of a broader trend.

Quest Diagnostics Inc. currently has a market capitalization of 26.8 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Yes. You can track Quest Diagnostics Inc. financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

Last quarter, Quest Diagnostics Inc. reported earnings of 2.88 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

Quest Diagnostics Inc. reported quarterly revenue of 2.91 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

Quest Diagnostics Inc. reported net income of 320 M for the last quarter. The previous quarter showed 252 M, which means net income changed by +26.98%.

Quest Diagnostics Inc. paid a dividend per share of 0.86. The current dividend yield is 1.57%. Dividend data can help income-focused investors evaluate the stock.

Quest Diagnostics Inc. currently has a dividend yield of 1.57%. Previously, the dividend yield was 1.66%, compared with 1.84% a year earlier. When evaluating dividend stocks, investors should also consider earnings, cash flow, and the sustainability of future dividend payments.

As of the latest available data, Quest Diagnostics Inc. has 57 K employees. Workforce size can provide additional context about the company's scale and operations.

Quest Diagnostics Inc. EBITDA is 474 M, and its EBITDA margin is 16.28%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

You can buy Quest Diagnostics Inc. (DGX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Investing in Quest Diagnostics Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the DGX chart and related analysis on metatrader.com as part of your research.